To evaluate the safety of double-dose transdermal scopolamine patch therapy. Randomized, crossover, double-blind study. Motion sickness clinic in Haifa, Israel. Twenty male sailors aged 18-21 years whose seasickness symptoms improved only slightly or not at all with a single transdermal scopolamine ...
scopolamineStudy Objective. To evaluate the safety of double-dose transdermal scopolamine patch therapy. Design. Randomized, crossover, double-blind study. Setting. Motion sickness clinic in Haifa, Israel. Participants. Twenty male sailors aged 18-21 years whose seasickness symptoms improved only ...